Critical Contrast: DIH Holding US (NASDAQ:DHAI) and PROCEPT BioRobotics (NASDAQ:PRCT)

PROCEPT BioRobotics (NASDAQ:PRCT) and DIH Holding US (NASDAQ:DHAI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Insider and Institutional Ownership

89.5% of PROCEPT BioRobotics shares are held by institutional investors. Comparatively, 27.8% of DIH Holding US shares are held by institutional investors. 17.4% of PROCEPT BioRobotics shares are held by insiders. Comparatively, 49.6% of DIH Holding US shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

PROCEPT BioRobotics has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, DIH Holding US has a beta of -0.57, suggesting that its share price is 157% less volatile than the S&P 500.

Profitability

This table compares PROCEPT BioRobotics and DIH Holding US’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-50.07%	-38.57%	-26.06%
DIH Holding US	N/A	-5.07%	3.35%

Earnings and Valuation

This table compares PROCEPT BioRobotics and DIH Holding US”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$136.19 million	30.21	-$105.90 million	($1.95)	-40.43
DIH Holding US	$64.47 million	0.82	-$8.44 million	N/A	N/A

DIH Holding US has lower revenue, but higher earnings than PROCEPT BioRobotics.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for PROCEPT BioRobotics and DIH Holding US, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	0	1	6	0	2.86
DIH Holding US	0	0	0	0	0.00

PROCEPT BioRobotics currently has a consensus price target of $97.86, suggesting a potential upside of 24.12%. Given PROCEPT BioRobotics’ stronger consensus rating and higher probable upside, equities analysts clearly believe PROCEPT BioRobotics is more favorable than DIH Holding US.

Summary

PROCEPT BioRobotics beats DIH Holding US on 7 of the 12 factors compared between the two stocks.

About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

About DIH Holding US

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.